-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FMFQLiXF5X76kA0Lnmt7Rzx09q0OcGzzchZVRuLBZCUZZd55G0MFMx9J6hPLTwgT wwqF0MrP4VdcjakWdAUrHA== 0001033409-10-000003.txt : 20101102 0001033409-10-000003.hdr.sgml : 20101102 20101102161548 ACCESSION NUMBER: 0001033409-10-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100915 FILED AS OF DATE: 20101102 DATE AS OF CHANGE: 20101102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 101158435 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-09-15 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001033409 ESHELMAN FREDRIC N 929 NORTH FRONT STREET WILMINGTON NC 28401 1 1 0 0 Executive Chairman Common Stock 2010-09-15 5 G 0 75000 0 D 7022871 D Common Stock 2010-09-29 5 G 0 62500 0 D 6960371 D Common Stock 2010-09-29 5 J 0 37500 0 D 462500 I GRAT Common Stock 2010-09-29 5 J 0 37500 0 A 6997871 D Common Stock 2010-10-25 5 J 0 38000 0 D 424500 I GRAT Common Stock 2010-10-25 5 J 0 38000 0 A 7035871 D Common Stock 11258 I LLC Common Stock 1685 I Spouse Stock Options (to buy) 20.45 2011-02-25 2020-02-25 Common Stock 103506 103506 D Stock Options (to buy) 25.74 2010-02-18 2019-02-18 Common Stock 103506 103506 D Stock Options (to buy) 19.94 2009-11-20 2018-11-20 Common Stock 51753 51753 D Stock Options (to buy) 43.26 2009-02-20 2018-02-20 Common Stock 103506 103506 D Stock Options (to buy) 32.47 2008-02-21 2017-02-20 Common Stock 51753 51753 D Stock Options (to buy) 33.44 2007-02-22 2016-02-21 Common Stock 207012 207012 D Stock Options (to buy) 20.47 2005-11-16 2014-11-15 Common Stock 258764 258764 D Stock Options (to buy) 14.78 2006-12-03 2013-12-02 Common Stock 124207 124207 D Stock Options (to buy) 14.44 2005-12-03 2012-12-02 Common Stock 41403 41403 D The Reporting Person made two gifts of stock in late September. The Reporting Person made two transfers from his Grantor Retained Annuity Trust, shown as an indirect holding, to himself in late September and late October. Exercise price and share amounts reflect an anti-dilution adjustment made in connection with the June 14, 2010 spin-off of Furiex Pharmaceuticals, Inc. The options were awarded on 2/25/10 and vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13. The options were awarded on 2/18/09 and vest in three equal increments on 2/18/08, 2/18/09 and 2/18/10. The options were awarded on 11/20/08 and vest as follows: 16,666 on 11/20/09, 16,667 on 11/20/10 and 16,667 on 11/20/11. The options were awarded on 2/20/08 and vest in three equal increments on 2/20/09, 2/20/10 and 2/20/11. The options were awarded on 11/16/04 and vest in four equal increments on 11/16/05, 11/16/06, 11/16/07 and 11/16/08. The options were awarded on 2/22/06 and vest in three equal increments on 2/22/07, 2/22/08 and 2/22/09. The options were awarded on 2/20/07 and vest as follows: 16,666 on 2/21/08, 16,667 on 2/21/09 and 16,667 on 2/21/10. Lisa C. Noecker attorney-in-fact for Fred N. Eshelman 2010-11-02 -----END PRIVACY-ENHANCED MESSAGE-----